FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI

The present study aimed to assess the correlation of fibroblast growth factor (FGF)-23 expression with clinical characteristics, then further explore its value in predicting 2-year in-stent restenosis (ISR) ri...

Source: BMC Cardiovascular Disorders - January 7, 2021 Category: Cardiology Authors: Tingting Song, Yang Fu, Yanbo Wang, Wei Li, Jiayu Zhao, Xun Wang, Haiyan Wang, Ying Zhao and Xianghua Fu Tags: Research article Source Type: research